Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cervical Cancer Test Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • GLO2773261
  • 122 Pages
  • September 2018
  • Medical Devices
Download Sample    Get Discount   
 
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.

Scope of the Report:

This report studies the Cervical Cancer Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cervical Cancer Test market by product type and applications/end industries.

Cervical cancer test market is dominated by United States in 2018. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.

A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.

The global Cervical Cancer Test market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cervical Cancer Test.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Hologic

Qiagen N.V.

Becton, Dickinson and Company

Hoffman-La Roche

Abbott Molecular

Arbor Vita Corporation

OncoHealth Corporation

Dell Guided Therapeutics, Inc.

CooperSurgical, Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pap Smear Test

HPV DNA Test

VIA Test

Market Segment by Applications, can be divided into

Hospitals

Laboratories

Physicians’ Offices & Clinics

Table of Contents

1 Cervical Cancer Test Market Overview

1.1 Product Overview and Scope of Cervical Cancer Test

1.2 Classification of Cervical Cancer Test by Types

1.2.1 Global Cervical Cancer Test Revenue Comparison by Types (2017-2023)

1.2.2 Global Cervical Cancer Test Revenue Market Share by Types in 2017

1.2.3 Pap Smear Test

1.2.4 HPV DNA Test

1.2.5 VIA Test

1.3 Global Cervical Cancer Test Market by Application

1.3.1 Global Cervical Cancer Test Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Laboratories

1.3.4 Physicians’ Offices & Clinics

1.4 Global Cervical Cancer Test Market by Regions

1.4.1 Global Cervical Cancer Test Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Cervical Cancer Test Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Cervical Cancer Test Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cervical Cancer Test Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Cervical Cancer Test Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cervical Cancer Test Status and Prospect (2013-2023)

1.5 Global Market Size of Cervical Cancer Test (2013-2023)

2 Manufacturers Profiles

2.1 Hologic

2.1.1 Business Overview

2.1.2 Cervical Cancer Test Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Hologic Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.2 Qiagen N.V.

2.2.1 Business Overview

2.2.2 Cervical Cancer Test Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Qiagen N.V. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.3 Becton, Dickinson and Company

2.3.1 Business Overview

2.3.2 Cervical Cancer Test Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Becton, Dickinson and Company Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.4 Hoffman-La Roche

2.4.1 Business Overview

2.4.2 Cervical Cancer Test Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Hoffman-La Roche Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.5 Abbott Molecular

2.5.1 Business Overview

2.5.2 Cervical Cancer Test Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abbott Molecular Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.6 Arbor Vita Corporation

2.6.1 Business Overview

2.6.2 Cervical Cancer Test Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Arbor Vita Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.7 OncoHealth Corporation

2.7.1 Business Overview

2.7.2 Cervical Cancer Test Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 OncoHealth Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.8 Dell Guided Therapeutics, Inc.

2.8.1 Business Overview

2.8.2 Cervical Cancer Test Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

2.9 CooperSurgical, Inc.

2.9.1 Business Overview

2.9.2 Cervical Cancer Test Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 CooperSurgical, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cervical Cancer Test Market Competition, by Players

3.1 Global Cervical Cancer Test Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Cervical Cancer Test Players Market Share

3.2.2 Top 10 Cervical Cancer Test Players Market Share

3.3 Market Competition Trend

4 Global Cervical Cancer Test Market Size by Regions

4.1 Global Cervical Cancer Test Revenue and Market Share by Regions

4.2 North America Cervical Cancer Test Revenue and Growth Rate (2013-2018)

4.3 Europe Cervical Cancer Test Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Cervical Cancer Test Revenue and Growth Rate (2013-2018)

4.5 South America Cervical Cancer Test Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)

5 North America Cervical Cancer Test Revenue by Countries

5.1 North America Cervical Cancer Test Revenue by Countries (2013-2018)

5.2 USA Cervical Cancer Test Revenue and Growth Rate (2013-2018)

5.3 Canada Cervical Cancer Test Revenue and Growth Rate (2013-2018)

5.4 Mexico Cervical Cancer Test Revenue and Growth Rate (2013-2018)

6 Europe Cervical Cancer Test Revenue by Countries

6.1 Europe Cervical Cancer Test Revenue by Countries (2013-2018)

6.2 Germany Cervical Cancer Test Revenue and Growth Rate (2013-2018)

6.3 UK Cervical Cancer Test Revenue and Growth Rate (2013-2018)

6.4 France Cervical Cancer Test Revenue and Growth Rate (2013-2018)

6.5 Russia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

6.6 Italy Cervical Cancer Test Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Cervical Cancer Test Revenue by Countries

7.1 Asia-Pacific Cervical Cancer Test Revenue by Countries (2013-2018)

7.2 China Cervical Cancer Test Revenue and Growth Rate (2013-2018)

7.3 Japan Cervical Cancer Test Revenue and Growth Rate (2013-2018)

7.4 Korea Cervical Cancer Test Revenue and Growth Rate (2013-2018)

7.5 India Cervical Cancer Test Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

8 South America Cervical Cancer Test Revenue by Countries

8.1 South America Cervical Cancer Test Revenue by Countries (2013-2018)

8.2 Brazil Cervical Cancer Test Revenue and Growth Rate (2013-2018)

8.3 Argentina Cervical Cancer Test Revenue and Growth Rate (2013-2018)

8.4 Colombia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Cervical Cancer Test by Countries

9.1 Middle East and Africa Cervical Cancer Test Revenue by Countries (2013-2018)

9.2 Saudi Arabia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

9.3 UAE Cervical Cancer Test Revenue and Growth Rate (2013-2018)

9.4 Egypt Cervical Cancer Test Revenue and Growth Rate (2013-2018)

9.5 Nigeria Cervical Cancer Test Revenue and Growth Rate (2013-2018)

9.6 South Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)

10 Global Cervical Cancer Test Market Segment by Type

10.1 Global Cervical Cancer Test Revenue and Market Share by Type (2013-2018)

10.2 Global Cervical Cancer Test Market Forecast by Type (2018-2023)

10.3 Pap Smear Test Revenue Growth Rate (2013-2023)

10.4 HPV DNA Test Revenue Growth Rate (2013-2023)

10.5 VIA Test Revenue Growth Rate (2013-2023)

11 Global Cervical Cancer Test Market Segment by Application

11.1 Global Cervical Cancer Test Revenue Market Share by Application (2013-2018)

11.2 Cervical Cancer Test Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Laboratories Revenue Growth (2013-2018)

11.5 Physicians’ Offices & Clinics Revenue Growth (2013-2018)

12 Global Cervical Cancer Test Market Size Forecast (2018-2023)

12.1 Global Cervical Cancer Test Market Size Forecast (2018-2023)

12.2 Global Cervical Cancer Test Market Forecast by Regions (2018-2023)

12.3 North America Cervical Cancer Test Revenue Market Forecast (2018-2023)

12.4 Europe Cervical Cancer Test Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Cervical Cancer Test Revenue Market Forecast (2018-2023)

12.6 South America Cervical Cancer Test Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Cervical Cancer Test Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Cervical Cancer Test Picture

Table Product Specifications of Cervical Cancer Test

Table Global Cervical Cancer Test and Revenue (Million USD) Market Split by Product Type

Figure Global Cervical Cancer Test Revenue Market Share by Types in 2017

Figure Pap Smear Test Picture

Figure HPV DNA Test Picture

Figure VIA Test Picture

Table Global Cervical Cancer Test Revenue (Million USD) by Application (2013-2023)

Figure Cervical Cancer Test Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Laboratories Picture

Figure Physicians’ Offices & Clinics Picture

Table Global Market Cervical Cancer Test Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Cervical Cancer Test Revenue (Million USD) and Growth Rate (2013-2023)

Table Hologic Basic Information, Manufacturing Base and Competitors

Table Hologic Cervical Cancer Test Type and Applications

Table Hologic Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Qiagen N.V. Basic Information, Manufacturing Base and Competitors

Table Qiagen N.V. Cervical Cancer Test Type and Applications

Table Qiagen N.V. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors

Table Becton, Dickinson and Company Cervical Cancer Test Type and Applications

Table Becton, Dickinson and Company Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Hoffman-La Roche Basic Information, Manufacturing Base and Competitors

Table Hoffman-La Roche Cervical Cancer Test Type and Applications

Table Hoffman-La Roche Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Molecular Basic Information, Manufacturing Base and Competitors

Table Abbott Molecular Cervical Cancer Test Type and Applications

Table Abbott Molecular Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Arbor Vita Corporation Basic Information, Manufacturing Base and Competitors

Table Arbor Vita Corporation Cervical Cancer Test Type and Applications

Table Arbor Vita Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table OncoHealth Corporation Basic Information, Manufacturing Base and Competitors

Table OncoHealth Corporation Cervical Cancer Test Type and Applications

Table OncoHealth Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Dell Guided Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors

Table Dell Guided Therapeutics, Inc. Cervical Cancer Test Type and Applications

Table Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table CooperSurgical, Inc. Basic Information, Manufacturing Base and Competitors

Table CooperSurgical, Inc. Cervical Cancer Test Type and Applications

Table CooperSurgical, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

Table Global Cervical Cancer Test Revenue (Million USD) by Players (2013-2018)

Table Global Cervical Cancer Test Revenue Share by Players (2013-2018)

Figure Global Cervical Cancer Test Revenue Share by Players in 2016

Figure Global Cervical Cancer Test Revenue Share by Players in 2017

Figure Global Top 5 Players Cervical Cancer Test Revenue Market Share in 2017

Figure Global Top 10 Players Cervical Cancer Test Revenue Market Share in 2017

Figure Global Cervical Cancer Test Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Cervical Cancer Test Revenue (Million USD) by Regions (2013-2018)

Table Global Cervical Cancer Test Revenue Market Share by Regions (2013-2018)

Figure Global Cervical Cancer Test Revenue Market Share by Regions (2013-2018)

Figure Global Cervical Cancer Test Revenue Market Share by Regions in 2017

Figure North America Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Europe Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure South America Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table North America Cervical Cancer Test Revenue by Countries (2013-2018)

Table North America Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure North America Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure North America Cervical Cancer Test Revenue Market Share by Countries in 2017

Figure USA Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Canada Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Mexico Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table Europe Cervical Cancer Test Revenue (Million USD) by Countries (2013-2018)

Figure Europe Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure Europe Cervical Cancer Test Revenue Market Share by Countries in 2017

Figure Germany Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure UK Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure France Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Russia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Italy Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Cervical Cancer Test Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Cervical Cancer Test Revenue Market Share by Countries in 2017

Figure China Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Japan Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Korea Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure India Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table South America Cervical Cancer Test Revenue by Countries (2013-2018)

Table South America Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure South America Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure South America Cervical Cancer Test Revenue Market Share by Countries in 2017

Figure Brazil Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Argentina Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Colombia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Cervical Cancer Test Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cervical Cancer Test Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cervical Cancer Test Revenue Market Share by Countries in 2017

Figure Saudi Arabia Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure UAE Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Egypt Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure Nigeria Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Figure South Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)

Table Global Cervical Cancer Test Revenue (Million USD) by Type (2013-2018)

Table Global Cervical Cancer Test Revenue Share by Type (2013-2018)

Figure Global Cervical Cancer Test Revenue Share by Type (2013-2018)

Figure Global Cervical Cancer Test Revenue Share by Type in 2017

Table Global Cervical Cancer Test Revenue Forecast by Type (2018-2023)

Figure Global Cervical Cancer Test Market Share Forecast by Type (2018-2023)

Figure Global Pap Smear Test Revenue Growth Rate (2013-2018)

Figure Global HPV DNA Test Revenue Growth Rate (2013-2018)

Figure Global VIA Test Revenue Growth Rate (2013-2018)

Table Global Cervical Cancer Test Revenue by Application (2013-2018)

Table Global Cervical Cancer Test Revenue Share by Application (2013-2018)

Figure Global Cervical Cancer Test Revenue Share by Application (2013-2018)

Figure Global Cervical Cancer Test Revenue Share by Application in 2017

Table Global Cervical Cancer Test Revenue Forecast by Application (2018-2023)

Figure Global Cervical Cancer Test Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Laboratories Revenue Growth Rate (2013-2018)

Figure Global Physicians’ Offices & Clinics Revenue Growth Rate (2013-2018)

Figure Global Cervical Cancer Test Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Cervical Cancer Test Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Cervical Cancer Test Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Cervical Cancer Test Revenue Market Forecast (2018-2023)

Figure Europe Cervical Cancer Test Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Cervical Cancer Test Revenue Market Forecast (2018-2023)

Figure South America Cervical Cancer Test Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Cervical Cancer Test Revenue Market Forecast (2018-2023)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450